Literature DB >> 6572931

Biology of Langerhans cells: selective migration of Langerhans cells into allogeneic and xenogeneic grafts on nude mice.

G G Krueger, R A Daynes, M Emam.   

Abstract

A major question challenging immunobiologists relates to those mechanisms that control the selective movement of cells involved in immune and inflammatory processes at various tissue sites such as the skin. Little is known about those influences that control the selective migration of macrophage-like Langerhans cells (LC) to normal epidermis, where it is uniformly distributed. Mechanistically, this includes the interaction of blood-borne LC precursors with the vascular endothelium of the skin and those factors that control the migration of the LC into the avascular epidermal component of the skin. By using (i) monoclonal antibodies specific for I-region associated Ia antigens found on LC from various inbred strains of animals and (ii) the congenitally athymic (nude) mouse as an immunologically compromised recipient of allografts and selected xenografts, we developed a model system to study the factors that restrict LC migration into the epidermis. Using this model, which excludes the need to lethally x-irradiate graft recipients, we established that: (i) the ingress of LC does not show major histocompatibility complex restriction [LC of the nude host are capable of migrating into the epidermis of allogeneic and certain xenogeneic (rat) skin grafts]; (ii) host LC are incapable of migrating into the epidermis of guinea pig or human skin grafts; (iii) the ingress of host LC into the epidermis of the graft is not accompanied by an overgrowth of the graft by host epidermis; and (iv) LC or LC precursors are capable of dividing in the skin or, alternatively, represent an extremely long-lived cell population. The specificity of this model system provides a powerful tool to help understand many aspects of LC biology. Grafting human skin to the nude mouse not only provides a biologic support system for the graft but also is, by design, a system that is devoid of contaminating circulating precursor cell types. Manipulation of the experimental conditions is quite easy and provides a highly specific means to investigate many parameters of LC function.

Entities:  

Mesh:

Year:  1983        PMID: 6572931      PMCID: PMC393660          DOI: 10.1073/pnas.80.6.1650

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Migration of lymphoblasts to the small intestine. II. Divergent migration of mesenteric and peripheral immunoblasts to sites of inflammation in the mouse.

Authors:  M L Rose; D M Parrott; R G Bruce
Journal:  Cell Immunol       Date:  1976-11       Impact factor: 4.868

2.  Cytochemical identification of ATPase-positive langerhans cells in EDTA-separated sheets of mouse epidermis.

Authors:  I C Mackenzie; C A Squier
Journal:  Br J Dermatol       Date:  1975-05       Impact factor: 9.302

3.  Langerhans cells form a reticuloepithelial trap for external contact antigens.

Authors:  W B Shelley; L Juhlin
Journal:  Nature       Date:  1976-05-06       Impact factor: 49.962

4.  A model implicating the Langerhans cell in keratinocyte proliferation control.

Authors:  C S Potten; T D Allen
Journal:  Differentiation       Date:  1976-01-13       Impact factor: 3.880

5.  Epidermal Langerhans cells bear Fc and C3 receptors.

Authors:  G Stingl; E C Wolff-Schreiner; W J Pichler; F Gschnait; W Knapp; K Wolff
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

6.  Ia antigen expression on human epidermal Langerhans cells.

Authors:  G Rowden; M G Lewis; A K Sullivan
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

7.  Langerhans cells: uptake of tritiated thymidine.

Authors:  L Giacometti; W Montagna
Journal:  Science       Date:  1967-07-28       Impact factor: 47.728

8.  Antigen-bearing langerhans cells in skin, dermal lymphatics and in lymph nodes.

Authors:  I Silberberg-Sinakin; G J Thorbecke; R L Baer; S A Rosenthal; V Berezowsky
Journal:  Cell Immunol       Date:  1976-08       Impact factor: 4.868

9.  Studies on the sensitization of animals with simple chemical compounds. XII. The influence of excision of allergenic depots on onset of delayed hypersensitivity and tolerance.

Authors:  E Macher; M W Chase
Journal:  J Exp Med       Date:  1969-01-01       Impact factor: 14.307

10.  Studies on the sensitization of animals with simple chemical compounds. XI. The fate of labeled picryl chloride and dinitrochlorobenzene after sensitizing injections.

Authors:  E Macher; M W Chase
Journal:  J Exp Med       Date:  1969-01-01       Impact factor: 14.307

View more
  14 in total

1.  Langerhans cells renew in the skin throughout life under steady-state conditions.

Authors:  Miriam Merad; Markus G Manz; Holger Karsunky; Amy Wagers; Wendy Peters; Israel Charo; Irving L Weissman; Jason G Cyster; Edgar G Engleman
Journal:  Nat Immunol       Date:  2002-11-04       Impact factor: 25.606

Review 2.  The role of graft-derived dendritic leukocytes in the rejection of vascularized organ allografts. Recent findings on the migration and function of dendritic leukocytes after transplantation.

Authors:  C P Larsen; J M Austyn; P J Morris
Journal:  Ann Surg       Date:  1990-09       Impact factor: 12.969

3.  Long-term productive human immunodeficiency virus infection of CD1a-sorted myeloid dendritic cells.

Authors:  Sergei Popov; Agnès-Laurence Chenine; Andreas Gruber; Pei-Lin Li; Ruth M Ruprecht
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Antigen processing: cultured lymph-borne dendritic cells can process and present native protein antigens.

Authors:  L M Liu; G G MacPherson
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

5.  Human Langerhans cells in epidermal cell culture, in vitro skin explants and skin grafts onto "nude" mice.

Authors:  J Czernielewski; M Demarchez; M Prunieras
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

Review 6.  Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin.

Authors:  Nikolaus Romani; Björn E Clausen; Patrizia Stoitzner
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

7.  Langerhans cells come in waves.

Authors:  Nikolaus Romani; Christoph H Tripp; Patrizia Stoitzner
Journal:  Immunity       Date:  2012-11-16       Impact factor: 31.745

8.  Development of an ex vivo human skin model for intradermal vaccination: tissue viability and Langerhans cell behaviour.

Authors:  Keng Wooi Ng; Marc Pearton; Sion Coulman; Alexander Anstey; Christopher Gateley; Anthony Morrissey; Christopher Allender; James Birchall
Journal:  Vaccine       Date:  2009-08-11       Impact factor: 3.641

9.  Severe combined immunodeficiency mouse and human psoriatic skin chimeras. Validation of a new animal model.

Authors:  B J Nickoloff; S L Kunkel; M Burdick; R M Strieter
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

10.  Migration of human antigen-presenting cells in a human skin graft onto nude mice model after contact sensitization.

Authors:  S Hoefakker; H P Balk; W J Boersma; T van Joost; W R Notten; E Claassen
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.